The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
Open accessAbstract
We assessed the feasibility of transplanting a sheet of retinal pigment epithelial (RPE) cells differentiated from induced pluripotent stem cells (iPSCs) in a patient with neovascular age-related macular degeneration. The iPSCs were generated from skin fibroblasts obtained from two patients with advanced neovascular age-related macular degeneration and were differentiated into RPE cells. The RPE cells and the iPSCs from which they were derived were subject to extensive testing. A surgery that included the removal of the neovascular membrane and transplantation of the autologous iPSC-derived RPE cell sheet under the retina was performed in one of the patients. At 1 year after surgery, the transplanted sheet remained intact, best corrected visual acuity had not improved or worsened, and cystoid macular edema was present. (Funded by Highway Program for Realization of Regenerative Medicine and others; University Hospital Medical Information Network Clinical Trials Registry [UMIN-CTR] number, UMIN000011929 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most prominent difference between these two trials is the use of allogeneic ESC-derived RPEs in the Sung trial, versus autologous iPSC-derived RPEs in the Mandai trial.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [88]
In the citing paper
“a critically important detail is the presence of copy-number variations in iPSC-derived RPEs revealed during genomic analysis, resulting in trial suspension citing safety concerns in adherence with Japanese iPSC laws.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [88]
In the citing paper
“a similar strategy utilizing iPSC-derived RPEs resulted in trial suspension over safety concerns88”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [88]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Prevalence of age-related maculopathy
Klein, R., Klein, B. E. K., & Linton, K. L. P. (1992) · Ophthalmology · doi:10.1016/s0161-6420(92)31871-8 · Cited by 1,845
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
Embryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61376-3 · Cited by 1,327
Prevalence of age-related maculopathy in Australia
Mitchell, P., Smith, W., Attebo, K., & Wang, J. J. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30846-9 · Cited by 1,062
Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZON
Rofagha, S., Bhisitkul, R. B., Boyer, D. S., Sadda, S. R., & Zhang, K. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.03.046 · Cited by 1,023
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Vingerling, J. R., Dielemans, I., Hofman, A., Grobbee, D. E., Hijmering, M., Kramer, C. F. L., & de Jong, P. T. V. M. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)31034-2 · Cited by 815
Kamao, H., Mandai, M., Okamoto, S., Sakai, N., Suga, A., Sugita, S., Kiryu, J., & Takahashi, M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.12.007 · Cited by 592
Self-citationGeneration of retinal cells from mouse and human induced pluripotent stem cells
Hirami, Y., Osakada, F., Takahashi, K., Okita, K., Yamanaka, S., Ikeda, H., Yoshimura, N., & Takahashi, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.035 · Cited by 421
Self-citationAge-Related Macular Degeneration
Fine, S. L., Berger, J. W., Maguire, M. G., & Ho, A. C. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002173420707 · Cited by 418
Song, W. K., Park, K.-M., Kim, H.-J., Lee, J. H., Choi, J., Chong, S. Y., Shim, S. H., Del Priore, L. V., & Lanza, R. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.04.005 · Cited by 393
Assawachananont, J., Mandai, M., Okamoto, S., Yamada, C., Eiraku, M., Yonemura, S., Sasai, Y., & Takahashi, M. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.03.011 · Cited by 357
Self-citationOuter Retinal Tubulation: A Novel Optical Coherence Tomography Finding
Zweifel, S. A. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.326 · Cited by 325
Shirai, H., Mandai, M., Matsushita, K., Kuwahara, A., Yonemura, S., Nakano, T., Assawachananont, J., Kimura, T., Saito, K., Terasaki, H., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512590113 · Cited by 321
Self-citationSubstrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue
Zhao, Y., Terry, D. S., Shi, L., Quick, M., Weinstein, H., Blanchard, S. C., & Javitch, J. A. (2011) · Nature · doi:10.1038/nature09971 · Cited by 311
(1994) · Archives of Ophthalmology · doi:10.1001/archopht.1994.01090160076025 · Cited by 234
Binder, S., Krebs, I., Hilgers, R.-D., Abri, A., Stolba, U., Assadoulina, A., Kellner, L., Stanzel, B. V., Jahn, C., & Feichtinger, H. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0118 · Cited by 231
Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD
Algvere, P. V., Gouras, P., & Dafgård Kopp, E. (1999) · European Journal of Ophthalmology · doi:10.1177/112067219900900310 · Cited by 219
Pathogenesis of lesions in late age-related macular disease
Holz, F. G., Pauleikhoff, D., Klein, R., & Bird, A. C. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.026 · Cited by 203
Prevalence of age related maculopathy in a representative Japanese population: the Hisayama study
Oshima, Y. (2001) · British Journal of Ophthalmology · doi:10.1136/bjo.85.10.1153 · Cited by 197
van Meurs, J. C., & Van Den Biesen, P. R. (2003) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(03)00384-2 · Cited by 163
(2004) · Ophthalmology · doi:10.1016/j.ophtha.2004.07.021 · Cited by 160
Kuroda, T., Yasuda, S., Kusakawa, S., Hirata, N., Kanda, Y., Suzuki, K., Takahashi, M., Nishikawa, S.-I., Kawamata, S., & Sato, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037342 · Cited by 157
Self-citationFalkner-Radler, C. I., Krebs, I., Glittenberg, C. G., Považay, B., Drexler, W., Graf, A. C., & Binder, S. (2010) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.176305 · Cited by 149
van Zeeburg, E. J. T., Maaijwee, K. J. M., Missotten, T., Heimann, H., & van Meurs, J. C. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.06.007 · Cited by 134
van Meurs, J. C. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.88.1.110 · Cited by 128
Sugita, S., Kamao, H., Iwasaki, Y., Okamoto, S., Hashiguchi, T., Iseki, K., Hayashi, N., Mandai, M., & Takahashi, M. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15619 · Cited by 73
Self-citationHeussen, F. M., Fawzy, N., Joeres, S., Lux, A., Maaijwee, K. J. M., Meurs, J. C., Kirchhof, B., & Joussen, A. M. (2007) · Eye · doi:10.1038/sj.eye.6702823 · Cited by 54
The end of submacular surgery for age-related macular degeneration? A meta-analysis
Falkner, C. I., Leitich, H., Frommlet, F., Bauer, P., & Binder, S. (2006) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0184-3 · Cited by 33
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges
Yamanaka, S. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.09.014 · Cited by 1,213
Self-citationGene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Gene therapy clinical trials worldwide to 2017: An update
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3015 · Cited by 903
da Cruz, L., Fynes, K., Georgiadis, O., Kerby, J., Luo, Y. H., Ahmado, A., Vernon, A., Daniels, J. T., Nommiste, B., Hasan, S. M., et al. (2018) · Nature Biotechnology · doi:10.1038/nbt.4114 · Cited by 706
Metadata
- Authors
- Mandai, M., Watanabe, A., Kurimoto, Y., Hirami, Y., Morinaga, C., Daimon, T., Fujihara, M., Akimaru, H., Sakai, N., Shibata, Y., Terada, M., Nomiya, Y., Tanishima, S., Nakamura, M., Kamao, H., Sugita, S., Onishi, A., Ito, T., Fujita, K., Kawamata, S., Go, M. J., Shinohara, C., Hata, K.-I., Sawada, M., Yamamoto, M., Ohta, S., Ohara, Y., Yoshida, K., Kuwahara, J., Kitano, Y., Amano, N., Umekage, M., Kitaoka, F., Tanaka, A., Okada, C., Takasu, N., Ogawa, S., Yamanaka, S., & Takahashi, M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-03-16
- Volume
- 376
- Issue
- 11
- Pages
- 1038-1046
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2601350462
- Cited by
- 1,509
- References
- 30
- FWCI
- 158.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.